Barker, Roger A.
Götz, Magdalena
Parmar, Malin
Article History
Received: 18 January 2018
Accepted: 15 March 2018
First Online: 16 May 2018
Competing interests
: M.P. is the owner of Parmar Cells AB and co-inventor on US patent applications 15/093,927 owned by Biolamina AB and EP17181588 owned by Miltenyi Biotec. Patent WO 2015/114059 A1 patents the use of BCL2 in reprogramming. R.A.B. and M.G. have no competing interests.